Bioidentical: More Than a Marketing Term
The term “bioidentical” has been used so liberally in wellness marketing that it has begun to lose its clinical meaning for many patients. Some dismiss it as a feel-good buzzword with no scientific substance; others treat it as an absolute endorsement of anything labeled bioidentical. The truth is more precise — and more clinically meaningful than either extreme suggests.
What “Bioidentical” Actually Means
A bioidentical hormone is one whose molecular structure is chemically identical to the hormone produced by the human body. This is a precise biochemical definition, not a marketing claim. Bioidentical estradiol-17β has the same molecular structure as the estradiol produced by human ovaries. Bioidentical testosterone has the same molecular structure as the testosterone produced by human Leydig cells. Bioidentical progesterone has the same molecular structure as the progesterone produced by the corpus luteum.
Synthetic hormones, by contrast, are molecules with modified structures designed to bind hormone receptors with varying affinity but with different overall pharmacological profiles — they are analogues, not identical molecules. Examples include medroxyprogesterone acetate (MPA, used in Prempro and Depo-Provera), norethindrone (used in many oral contraceptives), and conjugated equine estrogen (Premarin, derived from horse urine).
Why Molecular Identity Matters Clinically
The distinction matters because hormone receptors are highly specific. When a bioidentical molecule binds a hormone receptor, it triggers the full receptor activation pattern — including the downstream signaling cascades — that the natural hormone would activate. When a synthetic analogue binds the same receptor, the response may differ in timing, magnitude, or associated receptor interactions.
The clinical evidence for this distinction is most clear in several areas:
Progesterone vs. MPA and breast tissue: Micronized bioidentical progesterone appears to have a more favorable breast safety profile than synthetic progestins — particularly MPA, which was the progestogen used in the Women’s Health Initiative study that reported increased breast cancer risk. Subsequent studies using bioidentical progesterone (including the large French E3N cohort) have not shown the same signal.
Progesterone vs. MPA and sleep: Bioidentical progesterone’s metabolite allopregnanolone is a GABA-A receptor modulator that promotes sleep. Synthetic progestins do not share this property and in some cases worsen sleep quality.
Bioidentical vs. synthetic progestins and lipids: Synthetic progestins tend to reduce HDL cholesterol and have adverse metabolic effects not shared by micronized progesterone.
FDA-Approved vs. Compounded Bioidentical Hormones
An important nuance: not all bioidentical hormones are compounded. FDA-approved bioidentical hormone preparations include estradiol patches (Vivelle-Dot, Climara), estradiol gels (EstroGel, Elestrin), estradiol sprays (Evamist), oral estradiol tablets, vaginal estradiol preparations, and oral micronized progesterone (Prometrium). Compounded bioidentical hormones are prepared by compounding pharmacies in custom doses or formulations.
At Multigen Wellness, both FDA-approved bioidentical preparations and compounded formulations are used — based on clinical need, cost considerations, and delivery method preferences.
To discuss bioidentical hormone options tailored to your needs, call Multigen Wellness at (800) 259-0015. Transparent, evidence-based prescribing is our standard.